DGX raises 2026 growth guidance on strong utilization
The company raised its 2026 guidance, citing strong first-half results, consumer and partnership growth, and expected margin expansion as integration costs subside.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Quest Diagnostics raises 2026 guidance on utilization and margin outlook
Quest Diagnostics said it raised its 2026 guidance, citing robust utilization, expected margin expansion as integration costs subside, and growth momentum in its consumer business.